Related Experiment Video
Updated: Jun 23, 2026

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis
Wiebe Braam1, Marcel G Smits, Robert Didden
1's Heeren Loo Zuid, Wekerom, The Netherlands. Wiebe.Braam@sheerenloo.nl
Melatonin effectively treats sleep problems in individuals with intellectual disabilities. This meta-analysis found melatonin significantly reduced sleep latency and nighttime awakenings while increasing total sleep time.
Area of Science:
- Neuroscience
- Sleep Medicine
- Developmental Disabilities
Background:
- Recent meta-analyses question melatonin's efficacy for sleep issues in the general population.
- Previous trials suggest melatonin may benefit individuals with intellectual disabilities (ID).
Purpose of the Study:
- To evaluate the effectiveness of melatonin in treating sleep problems specifically in individuals with intellectual disabilities.
- To synthesize evidence from placebo-controlled randomized trials on melatonin for sleep disturbances in ID.
Main Methods:
- A meta-analysis was conducted on placebo-controlled randomized trials identified through PubMed, Medline, and Embase (1990-2008).
- Nine studies involving 183 individuals with ID were analyzed.
- Sleep latency, total sleep time, and number of nocturnal awakenings were primary outcome measures.
- Trial quality was assessed using the Downs and Black checklist.
Main Results:
- Melatonin treatment significantly decreased sleep latency by an average of 34 minutes (p<0.001).
- Total sleep time increased by an average of 50 minutes (p<0.001).
- The number of wakes per night was significantly reduced (p<0.05).
Conclusions:
- Melatonin is an effective treatment for sleep problems in individuals with intellectual disabilities.
- The findings support the use of melatonin to improve sleep quality and duration in this population.
Related Concept Videos
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Understanding Sleep
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
REM Sleep Behavior Disorder
RBD is significantly associated with...
